These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 43368)

  • 21. The emergence of ORG NC 45, 1- [2 beta,3 alpha,5 alpha,16 beta,17 beta)-3, 17-bis(acetyloxy)-2-(1-piperidinyl)-androstan-16-yl]-1-methylpiperidinium bromide, from the pancuronium series.
    Savage DS; Sleigh T; Carlyle I
    Br J Anaesth; 1980; 52 Suppl 1():3S-9S. PubMed ID: 6107102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man.
    Krieg N; Crul JF; Booij LH
    Br J Anaesth; 1980 Aug; 52(8):783-8. PubMed ID: 6107097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neuromuscular and autonomic blocking effects of azasteroids containing choline or acetylcholine fragments.
    Marshall IG; Harvey AL; Singh H; Bhardwaj TR; Paul D
    J Pharm Pharmacol; 1981 Jul; 33(7):451-7. PubMed ID: 6115032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromuscular blocking and ganglion blocking activities of some acetylcholine antagonists in the cat.
    Bowman WC; Webb SN
    J Pharm Pharmacol; 1972 Oct; 24(10):762-72. PubMed ID: 4403972
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of the neuromuscular blocking and vagolytic effects of ORG NC45 and pancuronium.
    Son SL; Waud BE; Waud DR
    Anesthesiology; 1981 Jul; 55(1):12-8. PubMed ID: 6113793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the human "isolated arm" preparation to indicate qualitative aspects of a new neuromuscular blocking agent, ORG NC 45.
    Bencini A; Agoston S; Ket J
    Br J Anaesth; 1980; 52 Suppl 1():43S-47S. PubMed ID: 6107105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonism of org NC 45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine.
    Gencarelli PJ; Miller RD
    Br J Anaesth; 1982 Jan; 54(1):53-6. PubMed ID: 6119998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of the muscle relaxant drug Org NC-45 and each of its hydroxy metabolites in dogs.
    Booij LH; Vree TB; Hurkmans F; Reekers-Ketting JJ; Crul JF
    Anaesthesist; 1981 Jul; 30(7):329-33. PubMed ID: 6115592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Sørensen B; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):501-5. PubMed ID: 6134536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of neuromuscular blockade by verapamil.
    Durant NN; Nguyen N; Katz RL
    Anesthesiology; 1984 Apr; 60(4):298-303. PubMed ID: 6703385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the neuromuscular blocking properties of ORG NC 45 and pancuronium in the rat, cat and rhesus monkey.
    Durant NN; Houwertjes MC; Crul JF
    Br J Anaesth; 1980 Aug; 52(8):723-30. PubMed ID: 6107096
    [No Abstract]   [Full Text] [Related]  

  • 33. Onset time and duration of action for atracurium, Org NC45 and pancuronium.
    Gramstad L; Lilleaasen P; Minsaas B
    Br J Anaesth; 1982 Aug; 54(8):827-30. PubMed ID: 6125161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.
    Fahey MR; Morris RB; Miller RD; Sohn YJ; Cronnelly R; Gencarelli P
    Anesthesiology; 1981 Jul; 55(1):6-11. PubMed ID: 6113794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative investigations on the cardiovascular effects of Org NC45 and pancuronium in dogs.
    Fitzal S; Gilly H; Ilias W
    Br J Anaesth; 1983 Jul; 55(7):641-6. PubMed ID: 6135434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolongation by bile salts of the duration of action of a steroidal neuromuscular blocking agent.
    Vonk RJ; Westra P; Houwertjes MC; Agoston S
    Br J Anaesth; 1979 Aug; 51(8):719-23. PubMed ID: 497068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of suxamethonium on the potency of ORG NC 45 in anaesthetized patients.
    Krieg N; Hendrickx HH; Crul JF
    Br J Anaesth; 1981 Mar; 53(3):259-62. PubMed ID: 6110433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
    Jones RS
    Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of atracurium, vecuronium (Org NC 45) and pancuronium.
    Gramstad L; Lilleaasen P; Minsaas B
    Br J Anaesth; 1983; 55 Suppl 1():95S-96S. PubMed ID: 6134541
    [No Abstract]   [Full Text] [Related]  

  • 40. The relationship between disposition and duration of action of congeneric series of steroidal neuromuscular blocking agents.
    Agoston S; Crul EJ; Kersten UW; Houwertjes MC; Scaf AH
    Acta Anaesthesiol Scand; 1977; 21(1):24-30. PubMed ID: 842267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.